Abstract: A dispensing system for a floor treatment composition. The dispensing system includes a housing partially enclosing a cavity and a cradle moveable within the housing along a z-axis from a first position to a second position. The dispensing system further includes a chassis and a sliding lock that includes an open frame. An inlet canula projects through the open frame. When the cradle is in the second position, the inlet canula entrance projects through the open frame and through a liquid transport aperture in the cradle. Latches extending from the open frame also project through engagement apertures in the cradle when the cradle is in the second position. The dispensing system further includes a pump in fluid communication with the inlet canula and a mop head in fluid communication with the pump.

Abstract: A coupling shell including a top wall, a shell wall, a front aperture in the top wall, a dispensing opening in the top wall, and a neck fitment projecting into the shell interior of the shell wall. The coupling shell can provide for a connection between a container and a dispensing system.

Abstract: A dispensing package for a floor treatment composition. The dispensing package includes a coupling shell and a container. The coupling shell is provided with a dispensing opening and at least one front aperture. The container includes a membrane seal engaged with a sealing surface of the container. The coupling shell can provide for a connection between a container and a dispensing system.

Abstract: A dispensing package for a floor treatment composition. The dispensing package includes a coupling shell and a container. The coupling shell is engaged with the container by a neck fitment projecting from the coupling shell. The coupling shell is provided with a dispensing opening and at least two support zones. The container includes a membrane seal engaged with a sealing surface of the container. The coupling shell can provide for a connection between a container and a dispensing system.

Abstract: A dispensing package for a floor treatment composition. The dispensing package includes a coupling shell and a container. The coupling shell is provided with a dispensing opening and at least one front aperture. The container includes a membrane seal engaged with a sealing surface of the container. The coupling shell can provide for a connection between a container and a dispensing system.

Abstract: A coupling shell including a top wall, a shell wall, a front aperture in the top wall, a dispensing opening in the top wall, and a neck fitment projecting into the shell interior of the shell wall. The coupling shell can provide for a connection between a container and a dispensing system.

Abstract: A cleaning apparatus is described. The cleaning apparatus includes a support member and a cleaning head. The support member includes a first portion having a length, a first end, an opposing second end and a handle disposed at the first end; a second portion having a first transition at the second end of the first portion and a second transition spaced from the first transition; a first support and a second support joining the first and the second transitions; and a liquid management system disposed, at least in part, between the first and second transitions. The liquid management system comprises a reservoir receiver. The cleaning head is moveably attached to the second transition. The support member exhibits a longitudinal angle of six degrees or less with respect to a horizontal plane. The cleaning apparatus exhibits a vertical height of less than 110 mm.

Abstract: A cleaning system that is appealing to consumers while utilizing display space in a store, the system containing a head and handle, wherein the handle comprises a first segment and a second segment located in a sleeve holding the first and second segments together in a generally aligned relationship, the sleeve further containing at least one cleaning refill.

Abstract: The present invention relates to 2,8,9-substituted purines which inhibit the extracellular release of inflammatory cytokines, said cytokines responsible for one or more human or higher mammalian disease states. The present invention further relates to compositions comprising said 2,8,9-substituted purines and methods for preventing, abating, or otherwise controlling enzymes which are understood to be the active components responsible for the herein described disease states.

Abstract: The present invention relates to 4-aryl triazoles having the formula: wherein R1 is independently selected from the group consisting of: lower alkyl, lower alkenyl, lower alkynyl, lower heteroalkyl, lower heteroalkenyl, lower heteroalkynyl, heterocycloalkyl, heteroaryl, halo, CN, OR4, SR4, S(O)R4, S(O)2R4, and NR4R5; and Q is has the general formula: said compounds are useful in treating diseases associated with unwanted cytokine activity, inter alia, interleukin-1 (IL-1) and tumor necrosis factor (TNF) from cells.

Abstract: The present invention relates to 4-aryl triazoles having the formula: wherein R1 is independently selected from the group consisting of: lower alkyl, lower alkenyl, lower alkynyl, lower heteroalkyl, lower heteroalkenyl, lower heteroalkynyl, heterocycloalkyl, heteroaryl, halo, CN, OR4, SR4, S(O)R4, S(O)2R4, and NR4R5; and Q is has the general formula: said compounds are useful in treating diseases associated with unwanted cytokine activity, inter alia, interleukin-1 (IL-1) and tumor necrosis factor (TNF) from cells.

Abstract: The present invention relates to 4-aryl triazoles having the formula: 1

Abstract: The present invention relates to 4-aryl triazoles having the formula: 1